OU biomedical engineering professor takes lead to conduct study to develop a COVID-19 vaccine booster – The Oklahoma Daily

An OU biomedical engineering professor is conducting a study to help develop a booster for a COVID-19 vaccine. 

According to a press release from the Gallogly College of Engineering, Wei R. Chen will lead researchers in the study, which is a collaboration with Immunophotonics, Inc., a biotech company located in St. Louis, Missouri. Immunophotonics is a private biotechnology company that is developing a proprietary carbohydrate polymer (IP-001), a potential treatment for a wide variety of tumor indications, for use. 

The study will determine the effectiveness of the drug IP-001 in producing immune responses as a booster for a COVID-19 vaccine.

“I am thankful for the confidence Immunophotonics has placed in me to lead this timely and important project during the COVID-19 outbreak,” Chen said in the release. “Being part of the possible solution to strengthen vaccine outcomes is a rewarding endeavor.” 

The Chen lab wants to prove IP-001 will make COVID-19 vaccines more effective in protecting against potential infections by boosting the protection against the disease, both in relation to potential antibody generation and/or a memory T cell response, per the release.

Michael Detamore, director of the Stephenson School of Biomedical Engineering, said that this partnership with Chen’s team is a beautiful example of translating research from the lab toward helping patients.

Editor’s Note: This post was updated at 10 a.m. Oct. 16 to reflect Michael Detamore is not the director of Immpunophonics, but the director of OU’s Stephenson School of Biomedical Engineering.

This post is password protected. Enter the password to view any comments.